Patient-Reported Outcomes with Consolidation Durvalumab Versus Placebo Following Concurrent Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 ADRIATIC Trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, cilt.21, sa.6, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 21 Sayı: 6
- Basım Tarihi: 2026
- Doi Numarası: 10.1016/j.jtho.2026.103564
- Dergi Adı: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
- Anahtar Kelimeler: ADRIATIC, Consolidation, Durvalumab, Limited-stage small cell lung cancer, Patient-reported outcomes
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet